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Abstract
Background: Rumex abyssinicus Jacq (Polygonaceae) is widely used in Ethiopia for treatment of wound and other
diseases. Although reports are available in the literature on some of the claimed activities, nothing has so far been
reported about the wound healing activity of R. abyssinicus. Thus, this work was initiated to investigate the wound
healing and anti-inflammatory activities of 80 % methanol extract of the rhizomes of R. abyssinicus in mice.
Methods: Following extraction of the rhizomes of the plant with 80 % methanol, the extract was formulated as
ointment (5 % & 10 % w/w) with simple ointment base B.P. The ointment was then evaluated for wound healing
activity using excision and incision wound models. Parameters, including wound contraction, epithelization time
and hydroxyproline content were determined using the excision model, whereas tensile strength was measured
from the incision model. In parallel, anti-inflammatory activity of the rhizome was evaluated with carrageenan
induced hind paw edema model by dissolving the 80 % methanol extract in 1 % carboxyl methyl cellulose and
administering orally in various doses (250, 500 and 750 mg/kg).
Results: Wound treated with 5 % and 10 % (w/w) hydroalcoholic extract ointment exhibited significant wound healing
activity in both models, as evidenced by increased wound contraction, shorter epithelization time, higher tissue breaking
strength and increased hydroxyproline content. The hydroalcoholic extract also produced dose-related significant
reduction (p < 0.05–0.001) of inflammation.
Conclusions: The results of this study demonstrated that the hydroalcoholic extract of the rhizomes of R. abyssinicus
facilitated wound healing at least in part via its anti-inflammatory activity, supporting its traditional claim as a wound
healing agent.
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Background
Wound may be described in different ways but the
most common definition is “loss or breaking of cellu-
lar and anatomic or functional continuity of living tis-
sues” [1, 2], and it can be broadly categorized as
acute or chronic wound [3, 4]. The healing of wound
is a complex process. At the time of injury, capillary
will be damaged and blood clot is formed. This is
followed by an early stage of inflammation. During
the early phase of inflammation, cells like neutrophils
and monocytes clean bacteria and necrotic tissue
through phagocytosis as well as release of enzymes
and toxic oxygen products. This is followed by migra-
tion of macrophage to wound area, which marks the
transition from early to late phase of inflammation.
The proliferative phase, which follows, is character-
ized by granulation and tissue proliferation formed
mainly by fibroblast and the angiogenesis process. Fi-
nally, reformulation and improvement in the compo-
nents of the collagen fiber that increases the tensile
strength will occur during the remodeling stage [3].
Thus, alterations in the inflammatory phase will im-
pact the overall integrity of the healing wound.
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Globally, wounds are a main cause of disability and
lost productivity. Apart from the incidence, chronic
wounds are known for causing different health prob-
lems. A study done in North European countries indi-
cated that foot ulcers cause up to 85 % of
amputations [5, 6]. In sub-Saharan African and South
Asian countries, 1 % to 2 % of the population faces
chronic wound at least once in their lifetime [7, 8].
More than 1.25 million people sustain burns and ap-
proximately 5 million suffer from non-healing wounds
each year in the US [9]. The cost of wound care is
substantial. Chronic wounds cost European countries
1 % to 2 % of their annual health care budget and $1
billion/year in the US [10]. This cost is unthinkable
for most people in developing countries suffering
from infected wounds [7]. Indirect costs such as psy-
chosocial damage and poor quality of life are also
major concerns [11].
Majority of the population in both developing and
some developed countries use traditional medicine for
their primary health care [12, 13]. In developing coun-
tries, like Ethiopia, management of skin diseases and
dermatological disorders such as cuts, wounds, and
burns has relied on medicinal plants for a long period of
time. Herbs are known to make the wounded area moist,
which is very essential for healing [14, 15]. Nowadays,
discovery is shifted towards wound healing promotion in
order to reduce hospitalization cost and serious compli-
cations [16]. Several lines of evidence have shown the
benefits of a wide variety of plants in their wound heal-
ing capacity [2, 17]. Thus, plant products are considered
to be the best and cost-effective substitutes for wound
treatment.
Rumex abyssinicus Jacq (Family; Polygonaceae) is the
most common traditional medicinal plant in the high-
lands of tropical Africa and distributed throughout
North Africa and Ethiopia. In the Ethiopian traditional
medicine, the rhizomes of R. abyssinicus (“Mekmeko” in
Amharic) are used to treat malaria, gonorrhea, poison-
ing, hepatitis, constipation, sciatic neuralgia, hyperten-
sion, migraine, rheumatism, breast cancer, stomach
distention, earache, liver diseases, hemorrhoids, typhus,
rabies and wound [18–22].
Previous reports indicated that 80 % methanol ex-
tract of the rhizomes of R. abyssinicus possessed anti-
microbial and in vitro anti-inflammatory activities
[21], diuretic and analgesic [22], and antimalarial [23]
activities. To date, however, no scientific report could
be found in the literature concerning the wound heal-
ing activity of the plant, although there is an ample
ethnobotanical claim for this property. This study was
therefore conducted to provide scientific evidence for




The fresh rhizomes of R. abyssinicus was collected from
Menagesha forest, located 40 km west of Addis Ababa,
Ethiopia. The plant was identified by a taxonomist and a
voucher specimen (E001/10) was deposited at the Na-
tional Herbarium, College of Natural and Computational
Sciences, Addis Ababa University (AAU) for future
reference.
Experimental animals
Healthy, adult Swiss albino mice of either sex (25–30 g,
and 6–8 weeks of age) purchased from the animal house
of the Ethiopian Public Health Institute and adult Wistar
rats of both sexes (200–300 g, aged 3–4 months) ob-
tained from the animal house of the School of Pharmacy,
AAU, were used for the study. The animals were housed
in cages under standard conditions (25 ± 2 °C, 55 ± 5 %
relative humidity, and 12 h light and dark cycles) and
provided with pellet diet and water ad libitum. The
study protocol was approved by the Ethics committee of
the School of Pharmacy, AAU. Animal handling and
care was carried out throughout the experiment follow-
ing international laboratory animal use and care guide-
lines [24].
Plant extraction
Rhizomes of R. abyssinicus were sliced to smaller pieces
and dried for three weeks under shade. The dried rhi-
zomes were then grinded to coarse powder. Five hun-
dred gram of the powder was then macerated with 80 %
methanol for three days in a conical flask with occa-
sional stirring and shaking. The extract was then filtered
(Whatman No. 1) and the residue was re-macerated
twice to obtain maximum yield. The combined filtrate
was then evaporated in a ventilated oven at 40 °C until
dried. The resulting dry extract was weighed and pro-
vided a percentage yield of 16.2 % (w/w). The dried ex-
tract was stored in a refrigerator for the preparation of
topical formulation (ointment).
Ointment formulation
Simple ointment of the 80 % methanol extract was pre-
pared following the formula (Table 1) described in the
Table 1 Formula used for preparation of the ointment
Ingredients MF RF
Wool fat 50 g 10 g
Hard paraffin 50 g 10 g
White soft paraffin 850 g 170 g
Cetostearyl alcohol 50 g 10 g
1000 g 200 g
MF, Master formula; RF, reduced formula
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British Pharmacopoeia [25]. Three ointment preparations
(each 200 g), with (5 % and 10 % w/w) and without (sim-
ple ointment only and served as a control) the extract
were formulated using the reduced formula from the mas-
ter formula (Table 1). All ingredients of the ointment base
were mixed and heated gently, with stirring until
homogenous and then stirred until cooled. For preparing
medicated ointment, 10 g and 20 g of the 80 % methanol
extract were mixed with 190 g and 180 g of the ointment
base, respectively, by levigation on the surface of the oint-
ment slab to make ointment of uniform consistency and
smooth texture [26]. In preparing the control ointment,
200 g of the base was taken and treated in the same man-
ner to formulate ointment without an active ingredient.
Acute dermal toxicity
For dermal toxicity, a total of 10 (5 female and 5 male)
rats were used. Animals showing normal skin texture
were housed individually in a cage and acclimatized to
the laboratory condition for five days prior to the test.
Following acclimation, around 10 % of the body surface
area fur was shaved 24 h before the study from the dor-
sal area of the trunk of the test animals. A limit test dose
of 2000 mg/kg of the 10 % formulation was applied uni-
formly over the shaved area for 24 h. At the end of the
exposure period, residual test substance was removed
and the animals were observed for development of any
adverse skin reactions daily for 14 days.
Grouping and dosing of animals
For excision model, four groups of mice, each containing
six animals were used. The first group was treated with
simple ointment, and served as a negative control. The
second and third groups were treated with 5 % and 10 %
of the extract ointment, respectively. The fourth group
was treated with nitrofurazone (0.2 %) and served as a
positive control. For incision model, five groups of mice,
containing six mice per group were used. The animals of
Group I-IV were treated in a similar fashion with excision
wound model, but animals in Group V were not treated
with any agents and served as untreated controls.
For assessment of anti-inflammatory activity, five
groups of mice containing six animal per group were
used. Group I was treated with 1 % carboxyl methyl cel-
lulose (CMC) and served as a negative control. Groups
II-IV were treated with 250 mg/kg, 500 mg/kg, and
750 mg/kg of the extract. Group V was treated with
indomethacin (10 mg/kg). Dose levels were chosen
based on acute oral toxicity results described elsewhere
[22] and dose calculation was based on Deshmukh et al.
[27], with slight modification. All administrations were
performed orally, with a maximum volume of 10 ml/kg.
The extract and the standard drug were dissolved in 1 %
CMC to obtain an oral suspension.
Excision wound model
On wounding day, animals were anesthetized using sub-
cutaneous injection of ketamine (1 ml/kg) and the back
hair of the animals was depilated by shaving. About
300 mm2 circular area was then marked and the full
thickness of the marked area was carefully excised by
using sharp sterilized scissors. After 24 h of wound cre-
ation, the ointments were applied gently once daily, ac-
cording to the respective grouping as described under
grouping and dosing section, to cover the wounded area
until complete healing was achieved. Wound contrac-
tion, epithelization period and hydroxyproline content
were monitored. Wound contraction was measured as
percent contraction every 2 days until complete wound
closure was achieved [12].
Measurement of wound contraction
The wound healing progress was evaluated by measuring
wound areas using a transparency sheet and a perman-
ent marker. The evaluated surface area was used to cal-
culate the percentage of wound contraction, taking
initial size of the wound (300 mm2) as 100 % [28] as
shown below:




The period of epithelization was calculated as the num-
ber of days required for falling off of the dead tissue
remnants without any residual raw wound [29].
Estimation of hydroxyproline content
Following treatment with the formulations for 10 days
of the circular wound created in the excision model,
each animal from the respective group was killed on
the 11th day using a high dose of anesthesia. The
wound tissue was then excised and its weight was re-
corded and placed in 10 % formalin and stored in a
refrigerator. On the day of the experiment, the tissue
was dried in an oven at 60 °C for 12 h and the dry
weight was again noted. The tissue was then hydro-
lyzed with 6 N HCl for 24 h at 110 °C in sealed glass
tubes. The hydrolysate was neutralized to pH 7 [30].
One ml of the supernatant solution was taken from
each of the acid hydrolysate and treated in the same
way to the standard hydroxyproline [31] and absorbance
was determined at a wave length of 572 nm in 1 cm cell.
The hydroxyproline content in each of sample solution
was calculated using the equation which was obtained
from the calibration curve (Fig. 1).
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Incision wound model
On wounding day, animals were anesthetized in the same
manner described for excision wound model. The dorsal fur
of each mouse was then shaved and a 3 cm long longitu-
dinal paravertebral incision was made through the skin and
subcutaneous tissue. The parted skin was then sutured 1 cm
apart using a surgical thread (no. 000) and curved needle
(no. 11). The continuous thread on both wound edges was
tightened for good closure of the wounds (Fig. 2a).
After 24 h of wound creation (on 1st day), animals
were treated as described under grouping and dosing
section, with topical formulation of vehicle, extract or
standard daily for nine days, leaving out the last group
which did not receive any of the interventions. The su-
tures were removed on day 8 post-incision and tensile
strength was measured on the 10th post-wounding day
using continuous water flow technique (Fig. 2b) [32] ac-
cording to the formulas shown below [33].
Percent Tensile strength TSð Þ of extract
¼ TS extract ‐ TS so
TS so
X100
Percent Tensile strength of reference
¼ TS reference ‐ TS so
TS so
X100
PercentTensilestrength ofs:o ¼ TSsoTSlu
TSlu
X100
Where so is simple ointment, and lu is left untreated.
Fig. 1 Calibration curve for estimating hydroxyproline concentration: tissue obtained from excision wound was hydrolyzed in 6 N HCl for 24 h at
110 °C in sealed glass tubes. The hydrolysate was neutralized to pH 7. One ml of the supernatant solution was taken from each tissue hydrolysate
and the absorbance was read
Fig. 2 Incision wound creation (a) and tensile strength measurement (b): The animals were anesthetized and then positioned on a tray between two
metal stands. To both stands, forceps of equal size were suspended with strings, one of which passing on a small wheel with the stands. Constantly
flowing water was then allowed to enter into the plastic bottle, which was suspended with the string paasing on the wheel until the wound breaks.
Wound was created at day 0 and treatment was started 24 h after wound creation (1st day) for nine days. The sutures were removed on
day 8 post-incision and tensile strength was measured on the 10th post-wounding day using continuous water flow technique
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Anti-inflammatory activity
Anti-inflammatory activity of R. abyssinicus was deter-
mined using mouse paw edema model. Following over-
night fasting with free access to water, the basal volume
of the right hind paw of each mouse was determined be-
fore administration of any drug using plethysmometer
(Ugo Basile, Italy) [34]. After determination of the basal
volume, the animals were divided into five groups such
that the mean volume of the different groups were simi-
lar. The mice were then treated as described under
grouping and dosing section 1 h before carrageenan in-
jection. Paw swelling was induced by subplantar injec-
tion of 0.05 ml of a solution of 1 % carrageenan in 0.9 %
saline (w/v) into the right hind paw. The inflammation
was quantified by measuring the volume displaced by the
paw 1, 2, 3 and 4 h after carrageenan injection. Results
were expressed as the paw volume (ml) variation with re-
spect to the basal values. The percentage inhibition of
edema for each group was calculated using the following
formula [35]:
Percentage inhibition of edema ¼ Co ‐ Ct
Co
X100
Where Co is the average inflammation (hind paw
edema) of the control group at a given time; and Ct is
the average inflammation of the plant extract or indo-
methacin treated mice at the same time.
Statistical analysis
Raw data obtained from both wound and mouse paw
edema models are expressed as mean ± SEM. The data
were analyzed using SPSS version 17.0 and differences
among groups were compared with one-way ANOVA
followed by Post Hoc Tukey test. The data were consid-
ered significant at p < 0.05.
Results
Acute dermal toxicity
Maximum concentration of the ointment (10 % (w/w))
administered at a limit dose of 2000 mg/kg was found to
be safe. After 24 h of application of the ointment, the
site did not show any sign of inflammation (Fig. 3).
There were also no overt signs and symptoms observed
when the animals were monitored for 48 h. Moreover,
no signs of toxicity as well as no mortality were noted
during the 14 days cage side observation.
Effect on excision wounds
Wound contraction
Topical application of both 5 % and 10 % of the hydroal-
coholic extract ointments in excision wound model sig-
nificantly increased wound contraction rate compared to
controls, with variable onset of action (Table 2 & Fig. 4).
Whilst 5 % ointment produced a significant contraction
on the 7th day (p < 0.01), 10 % produced on the 3rd day
(p < 0.001). In addition, the contraction produced by the
10 % ointment was significantly greater (p < 0.01) than
that of the 5 % on the 3rd and 5th day. No apparent dif-
ference was, however, observed thereafter between the
two concentrations until the end of the observation
period (Fig. 3). The 10 % ointment also appeared to pro-
vide better wound contraction than the reference com-
pound until day 13, although the difference failed to
reach statistical significance.
Epithelization period
Table 3 shows epithelization period of excision wound of
all formulations tested. Animals treated with the extract
as well as the standard exhibited shorter epitthelization
period than the controls. Time for epithelization was
shorter by 23.1 % for 10 % (p < 0.001), 22.1 % for nitro-
furazone (p < 0.001) and 16.3 % for 5 % (p < 0.05) com-
pared to those treated with the ointment base. However,
no apparent difference in epithelization period was
found between the extract and the standard as well as
between the different concentrations of the extract.
Estimation of hydroxyproline content
Hydroxyproline content of wound tissues following
10 days after treatment is depicted in Table 4. Hydroxy-
proline levels were significantly greater in animals treated
with the extract as well as the standard compared to con-
trols. Looking at the percentage increase, nitrofurazone
achieved the maximum increase (102.2 %, p < 0.001)
followed by 10 % (74.2 %, p < 0.001) and 5 % (31.6 %,
p < 0.05) of the extract ointment. Once again, al-
though there appeared to be a difference in mean
Fig. 3 Photograph of skin 24 h after application of 10 % ointment of
80 % methanol extract of the rhizome of Rumex abyssinicus for acute
dermal toxicity study: a limit dose of 2000 mg/kg was applied topically
to assess dermal toxicity and no sign of inflammation was observed
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increase values among the treatment, the difference
did not reach statistical significance.
Incision wounds
The mean tensile strength in the group treated with
simple ointment base BP tended to increase by about
19.4 % compared to untreated controls, which failed to
reach statistical significance. Tensile strength was, how-
ever, significantly increased by about 36.2 % (p < 0.05),
57.2 % (p < 0.001), and 79.1 % (p < 0.001) with 5 %,
10 % of the extract and nitrofurazone ointment, re-
spectively, compared to controls treated with the oint-
ment base (Table 5). The tensile strength of animals
treated with the standard drug was significantly higher
(p < 0.01) than the 5 % extract treated animals, although
no apparent difference was detected with 10 % formula-
tion of the extract.
Anti-inflammatory test
Table 6 summarizes anti-inflammatory activity of the ex-
tract in mouse paw edema. Treatment with neither the ex-
tract nor the standard produced anti-inflammatory activity
one hour following inflammation induction compared to
controls. However, the two higher doses of the extract (500
and 750 mg/kg) as well as the standard drug significantly
(p < 0.001) inhibited edema after 2 h of carrageenan injec-
tion. On the other hand, the lower dose (250 mg/kg) of the
extract displayed anti-inflammatory activity (p < 0.05) after
3 h of edema induction.
Discussion
Wound healing is a complex process that cannot be
understood by using a single model or relying on an in
vitro study. Better understanding of the healing process
necessitates the use of two or more different in vivo
models [36]. Wound healing includes an acute inflam-
matory phase accompanied by collagen synthesis, which
finally form a scar. Currently available drugs can’t affect
all phases of wound healing, calling for the need for de-
veloping new drugs from different sources. Rapid healing
requires fast wound contraction, shorter epithelization
period and adequate gain of tensile strength. Biochem-
ical markers, including tissue DNA, RNA, total protein,
and hydroxyproline are indicative of better healing qual-
ity of drugs [37, 38]. Thus, in the present study, an at-
tempt was made to evaluate the potential wound healing
Table 2 Effect of topical application of the ointment formulated from 80 % methanol extract of the rhizomes of Rumex abyssinicus
on wound contraction of excision wound model in mice
Group Wound area (mm2) on post-wounding days
3 5 7 9 11 13 15
SO 234.2 ± 11.8 202.0 ± 10.6 159.1 ± 13.0 110.0 ± 8.5 33.5 ± 5 20.5 ± 2.7 9.2 ± 3.0
5 % HEO 179.3 ± 23.3 150 ± 15.0 80.2 ± 21.7a2 27.3 ± 11.4a2 10 ± 6a2 2 ± 1.4a3 0a2
10 % HEO 82.4 ± 8.1 a3,c2 72.67 ± 9.2a3,c2 39.1 ± 8.1a3 11.0 ± 3.0a3 1.8 ± .5a3 0a3 -
NFO 130.7 ± 17.0a2 108.5 ± 17.4a3 54.5 ± 10.7a3 17.2 ± 4.8a3 4.8 ± 2a3 1.67 ± 1.3a3 0a2
n = 6 animals in each group; Values are expressed as mean ± SEM and analyzed by one way ANOVA followed by tuckey post hoc test; SO, simple ointment base;
HEO, hydroalcoholic extract ointment; NFO, nitrofurazone ointment;.numbers (3-15) refer days where measurment was taken following wound creation; 0 values
refer day where complete healing was achieved; aagainst control, cagainst 5 % (w/w) hydroalcoholic extract; 2p < 0.01, 3p < 0.001
Fig. 4 Effect of 80 % methanol extract of Rumex abyssinicus rhizomes on the percentage wound closure of the excision wound model: n = 6
animals in each group; Values are expressed as mean ± SEM; SO, simple ointment base; HEO, hydroalcoholic extract ointment; NFO, nitrofurazone
ointment. Percent wound closure increased significantly with the extract across time compared to controls. Maximum closure was achieved on
day 11, which was 13 and 15 from the standard and vehicle, respectively
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activity of R. abyssinicus, a medicinal plant used for
wound healing in Ethiopian folklore medicine using the
two most important wound models i.e., excision and in-
cision wound models.
In excision wound model, the ointment formulated
from the hydroalcoholic extract of the rhizomes of R.
abyssinicus showed significant increase in percentage
closure of excision wounds (Table 2 & Fig. 4). During
the proliferative phase of wound healing, wound con-
traction enhances closure of the defect by pulling the
edges of the wound towards the center [39]. Contraction
decreases healing time because it decreases the size of
the wound and reduces the amount of extracellular
matrix needed to repair the defect. Contraction also fa-
cilitates re-epithelization by shortening the distance mi-
grating keratinocytes must travel [40]. Moreover, the
wound will close at fast rate, if the medication is more
efficient [41]. The effect of the rhizomes of R. abyssini-
cus on wound contraction points to the fact that the ex-
tract is endowed with pro-healing action as wound
contraction accounts for 88 % of the healing process
(the remaining healing is due to scar formation) [42]. Al-
though the mechanism by which the extract increased
wound contraction remains to be seen, it is plausible to
suggest that it might be attributed to either the plant’s
anti-inflammatory effect (present study) or induction of
macrophage cell proliferation [21].
In this study, the epithelization time was also found to
be significantly shorter in animals treated with oint-
ments containing the crude extract (Table 3). Epitheliza-
tion involves the proliferation and migration of epithelial
cells across the wound bed [43]. Therefore, the shorter
epithelization time in the hydroalcoholic extract might
be due to facilitated proliferation of epithelial cells and/
or increasing the viability of epithelial cells [30]. A large
body of evidence indicates that antimicrobial activity
correlates with wound healing. Infection can seriously
delay healing process by causing poor quality granula-
tion tissue formation, reduced tensile strength of con-
nective tissue, impaired epithelization and odor [14, 44].
Hence, increased rate of wound contraction and de-
crease in period of epithelization in the animals treated
with the extract in excision wound model could also be
attributed to the R. abyssinicus’s antimicrobial activity, as
such activity is reported earlier for the plant [21].
Wound re-epithelization is a hallmark of successful
wound care [45]. Moreover, better healing activity is dis-
tinguished with short epithelization period [46]. Thus,
shorter epithelializtion periods in animals treated with
the extract reinforces the notion that R. abyssinicus has
a potential application as a wound healing agent.
Hydroxyproline is an amino acid that is found in colla-
gen and measuring its level indicates collagen turnover
[47]. The hydroxyproline content in mice treated with
ointment containing the extract was significantly higher
than controls, but comparable to the standard (Table 4).
Higher hydroxyproline content in the extract and stand-
ard treated group might be related to enhancement of
the proliferation and migration of fibroblasts and colla-
gen deposition [48]. Thus, it is conceivable to suggest
that the observed decrease in epithelization and increase
in wound contraction with application of the extract
could be due to the plant’s potential to increase collagen
synthesis through its effect on hydroxyproline content,
as wound contraction begins almost concurrently with
collagen synthesis [1].
Better efficacy of the crude extract in wound heal-
ing was further evidenced by the breaking strength in
incision wounds (Table 5). Higher tensile strength is
an indication of better wound healing [49] and it
mainly depends on the increase in collagen concen-
tration and stabilization of the fibers. Hence, based
on the amount of hydroxyproline detected, it could
be assumed that the crude extract enhanced the
strength of the incision wound by increasing the col-
lagen levels, which could stick the wound edges to-
gether at the repaired site [45].
Inflammation is important in wound healing. During
acute wound it makes wound bed to be healed by re-
moving necrotic tissue, debris, and bacterial contami-
nants as well as recruiting and activating fibroblasts.
Table 3 Effect of topical application of the ointment formulated
from 80 % methanol extract of the rhizomes of Rumex
abyssinicus on epithelization period
Group Epithelization period (days)
SO 17.3 ± 0.333
5 % HEO 14.5 ± 0.764a2
10 % HEO 13.3 ± 0.333a3
NFO 13.5 ± 0.671a3
n = 6 animals in each group; Values are expressed as mean ± SEM and
analyzed by one way ANOVA followed by tuckey post hoc test; SO, simple
ointment base; HEO, hydroalcoholic extract ointment; NFO, nitrofurazone
ointment;. aagainst control; 2p < 0.01, 3p < 0.001
Table 4 Hydroxyproline content of excision wounds following
topical application of the ointment formulated from 80 %
methanol extract of the rhizomes of Rumex abyssinicus
Group Hydroxyproline (mg/100 g)
SO 10.6 ± 0.92
5 % HEO 13.9 ± 0.89a1
10 % HEO 18.5 ± 0.70a3
NFO 21.6 ± 0.86a3
n = 6 animals in each group; Values are expressed as mean ± SEM and
analyzed by one way ANOVA followed by tuckey post hoc test; Hydroxyproline
was determined following treatment for 10 days; SO, simple ointment base;
HEO, hydroalcoholic extract ointment; NFO, nitrofurazone ointment;. aagainst
control;1p < 0.05, 3p < 0.001
Mulisa et al. BMC Complementary and Alternative Medicine  (2015) 15:341 Page 7 of 10
Under normal conditions, inflammation is a self-limiting
process. Excessive inflammation, however, limits wound
healing [11]. The extract showed anti-inflammatory ac-
tivity in carrageenan induced paw edema model in mice
(Table 6). Carrageenan is widely used to induce hind
paw edema for the discovery and evaluation of anti-
inflammatory drugs [34]. Carrageenan injection induces
inflammation within short period of time. It produces
three distinct phases: first (0–1.5 h), second (1.5–2.5 h)
and third (2.5–5 h) phases of inflammation. The media-
tors of inflammation involved are histamine and sero-
tonin, bradykinin, and prostaglandins for the three
phases, respectively. The third phase is mostly used to
assess anti-inflammatory effect of traditional medicinal
plants, as this phase is sensitive to most clinically effect-
ive anti-inflammatory drugs [50]. Neither of the treat-
ments produced effect in the first hour, suggesting less
responsiveness of phase one mediators to the tested
agents (Table 5). Inhibition was, however, apparent fol-
lowing the 2nd hour, the only exception being 250 mg/kg
of the extract. This observation could possibly indicate
that phase 2 mediators’ response might vary with dose.
On the other hand, all doses of the extract were effective
from the 3rd hour onwards, regardless of the dose levels
used, pointing to the fact that phase 3 mediators are the
most likely targets for the extract. There appears also to
be an in vitro and in vivo correlation, as in vitro anti-
inflammatory activity for the plant has been described in
previous reports [21]. Moreover, this finding is concordant
with earlier reports showing that plants having anti-
inflammatory activity do also exhibit wound healing
effect [11].
The 80 % methanol extract of the rhizomes of R. abys-
sinicus had been reported to possess secondary metabo-
lites, including, among others, tannins, saponins,
flavonoids, steroids and anthraquinones [22]. Flavonoids
and tannins have been shown to be important for wound
healing due to their antioxidant, anti-inflammatory and
antibacterial activities. In line with this notion, published
reports indicate that hydroalcoholic extract of Rumex
crispus [51], R. maderensis [52], R. acetosa, R. patientia
[53], Polygonum convolvulus, Rheum undulatum, and R.
acetosella [54] possess wound healing activity because of
their phenolic (such as flavonoids and tannins) content.
Active constituents such as chrysophanol, emodin and
physcion were also previously isolated from the rhizomes
of R. abyssinicus [55]. Emodin [37, 56] and chrysophanol
[57] isolated from other plant species are reported to have
antimicrobial, anti-inflammatory and wound healing activ-
ities. In addition, majority of the Rumex species have also
been reported to have antimicrobial action due to the pres-
ence of physcion and rumicin [19]. Taken together, these
findings collectively indicate that phytoconstituents indi-
vidually or synergistically may initiate a host of mechanisms
responsible for the wound healing activity of R. abyssinicus.
Although histopathological studies are not performed that
could have provided data with regeneration of the epithe-
lium and disposal of the collagen, the measured parameters
Table 5 Effect of topical application of the ointment formulated from 80 % methanol extract of the rhizomes of Rumex abyssinicus
on tensile strength of incision wound
Group Tensile strength (g) (mean ± SEM) % Tensile strength
Untreated control 205.4 ± 19.5 -
SO 244.67 ± 17.1 19.4 %
5 % HEO 333.33 ± 18.2a1 36.2 %
10 % HEO 384.50 ± 19.6a3 57.2 %
NFO 438.17 ± 19.1c2,a3 79.1 %
n = 6 animals in each group; Values are expressed as mean ± SEM and analyzed by one way ANOVA followed by tuckey post hoc test; tensile strength was
measured on the 10th post-wounding day using continuous water flow technique; SO, simple ointment base; HEO, hydroalcoholic extract ointment; NFO,
nitrofurazone ointment; aagainst control treated with simple ointment base;c against 5% (w/w) hydroalcoholic extract;1p < 0.05, 2p < 0.01, 3p < 0.001
Table 6 Anti-inflammatory activity of 80 % methanol extract of the rhizomes of Rumex abyssinicus on carrageenan-induced mice
paw edema following oral administration
Group Mean change in the paw volume (ml)
Basal 1 h 2 h 3 h 4 h
Control 0.50 ± 0.04 0.61 ± 0.02 0.7 ± 0.03 0.69 ± 0.04 0.65 ± 0.03
Extract (250 mg/kg) 0.50 ± 0.02 0.60 ± 0.03 (1.64 %) 0.58 ± 0.04 (17 %) 0.55 ± 0.02a1 (20.29 %) 0.51 ± 0.02a2 (21.54 %)
Extract (500 mg/kg) 0.50 ± 0.03 0.55 ± 0.02 (9.84 %) 0.47 ± 0.04a3 (32.86 %) 0.44 ± 0.02a3 (36.23 %) 0.30 ± 0.03a3c3 (53.85 %)
Extract (750 mg/kg) 0.51 ± 0.01 0.48 ± 0.04 (21.31 %) 0.43 ± 0.02a3,c1 (38.57 %) 0.40 ± 0.04a3,c2 (42.03 %) 0.25 ± 0.02a3c3 (61.54 %)
Indomethacin (10 mg/kg) 0.53 ± 0.03 0.48 ± 0.03 (24.6 %) 0.35 ± .02a3c3 (50 %) 0.24 ± 0.02a3c3 (65 %) 0.10 ± 0.02a3c3 (84.6 %)
n = 6 animals in each group; Values are expressed as mean ± SEM, with inhibition deppicted in parenthesis; data were analyzed by one way ANOVA followed by
tuckey post hoc test;; aagainst control, cagainst 250 mg/kg; 1p < 0.05, 2p < 0.01, 3p < 0.001
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consistently showed that the plant is endowed with favor-
able wound healing activities. Preparations are underway to
isolate the compound (s) responsible for the observed activ-
ities in subsequent studies.
Conclusions
The data generated from the present study indicated that
the crude extract of the rhizomes R. abyssinicus increased
wound contraction, breaking strength of the repaired tis-
sue and hydroxylproline content. These findings highlight
the potential wound healing activity of the plant and up-
hold the traditional claims of the plant for the treatment
of wounds. The hydroalcoholic extract was also endowed
with significant anti-inflammatory activities that explain,
at least in part, its wound healing activity.
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